Telemedicine is definitely here to stay, but recent study may offer clues on its sustaining power.
Alex Colborn
Advertisement
Articles by Alex Colborn
Advertisement
Latest Updated Articles
Virtual’s Long-View Reality: Future Priorities and PerspectivesFebruary 11th 2021
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Gilead Acquires Oral IL-23R Inhibitor From PepStar for $1.275 Billion, Zymeworks Licenses DLL3-Targeting T Cell Engager to Roche
2
Treasury Proposes Rules Adding Biotechnology to Outbound Investment Security Program
3
FDA Approves Hibsago (Bepirovirsen) for Chronic Hepatitis B
4
FDA Grants Ultomiris Accelerated Approval in the U.S. for Adults with Primary Immunoglobulin A Nephropathy
5